CompletedNot Applicable

A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan

Japan3,026 participantsStarted 2013-05

Plain-language summary

The objective of this five-year prospective observational follow-up study is to examine the additional benefits of using cardio-ankle vascular index (CAVI) as a predictive indicator of cardiovascular events in high-risk patients.

Who can participate

Age range40 Years – 74 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Type 2 diabetes mellitus
✓. Metabolic syndrome
✓. Grade I to III hypertension with the third layer of risk factors according to the guidelines for the management of hypertension japanese society of hypertension(JSH)2009
✓. Chronic kidney disease(stage G3a or G3b) according ot the clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan
✓. History of coronary artery disease or noncardiogenic cerebral infarction

Exclusion criteria

✕. Under 40 years of age or over 74 years of age
✕. An ankle-brachial index less than 0.9
✕. Chronic atrial fibrillation
✕. Current symptoms of heart failure(NYHA class III or IV) or left ventricular dysfunction (EF below 40%)
✕. Malignancy
✕. Chronic kidney disease(G4 or G5)according ot the clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan
✕. chronic dialysis due to renal failure
✕. Taking steroids/immunosuppressants

What they're measuring

major cardiac events

Timeframe: five years

Trial details

NCT IDNCT01859897

SponsorCAVI-J Study Group

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-06

View on ClinicalTrials.gov More Stroke trials